| 000 | 01557 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514000011.0 | ||
| 264 | 0 | _c20010920 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a0897-7194 | ||
| 024 | 7 |
_a10.3109/08977190009003246 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Boer, R H | |
| 245 | 0 | 0 |
_aPharmacokinetic analysis of pegylated megakaryocyte growth and development factor in humans. _h[electronic resource] |
| 260 |
_bGrowth factors (Chur, Switzerland) _c2000 |
||
| 300 |
_a215-26 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEnzyme-Linked Immunosorbent Assay _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aNeoplasms _xblood |
| 650 | 0 | 4 | _aPlatelet Count |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 |
_aThrombopoietin _xadministration & dosage |
| 700 | 1 | _aRoskos, L K | |
| 700 | 1 | _aCheung, E | |
| 700 | 1 | _aFox, S | |
| 700 | 1 | _aBasser, R L | |
| 700 | 1 | _aMarty, J | |
| 700 | 1 | _aBegley, C G | |
| 700 | 1 | _aCebon, J | |
| 773 | 0 |
_tGrowth factors (Chur, Switzerland) _gvol. 18 _gno. 3 _gp. 215-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/08977190009003246 _zAvailable from publisher's website |
| 999 |
_c11267742 _d11267742 |
||